2022 Cancer Research Trust Enabling Grant

The Cancer Research Trust Enabling Grants were established in 2009 to promote and support collaborative cancer research in WA and make a globally-significant contribution to the diagnosis, prevention and treatment of cancer.

 

Award: 2022 Cancer Research Trust Enabling Grant
Recipient: Prof Alistair Forrest
Description:

Tumours contain many different normal cell types that interact with the cancer cells. Although some cell types are associated with good or poor prognosis, relatively little is known about all the cell types that exist in a tumour. The team will use new ‘single cell technologies' that look at the cells DNA to study hundreds of tumour samples from many different cancer types donated by patients across Perth. This will provide new insights into what cell types are present in each tumour and determine the genes switched on and off in thousands of cells from each patient's tumour.

This information will be used to study four priority areas: What cell types are present in each tumour? ; Which drugs might kill these cancer cells, what fraction of cancer cells are likely to be resistant and why are some cancers resistant?; What changes between the cancer cells in a primary site when they move to a metastatic site?; and can new biomarkers be identified for early cancer detection and can cancer cells be detected in the blood?

Funding from Cancer Council WA: $25,000 in 2022 (total $250,000 for 2018-2022)
Supported:

Award: 2022 Cancer Research Trust Enabling Grant
Recipient: Prof Christobel Saunders AO
Description: The Chair provides academic leadership in clinical cancer research in WA and aims to increase the participation of local cancer patients in clinical trials of new cancer treatments.

The purpose of funding the Cancer Foundation Chair in Clinical Cancer Research is to improve the clinical care available to people diagnosed with cancer in Western Australia. There is compelling evidence that outcomes for patients are improved when they participate in clinical trials. A key vehicle therefore to improve outcomes in Western Australia is to actively promote clinical trials in the medical and general community. The means by which this may be achieved by the Chair are broken down into the following categories:
• Research
• Clinical trials
• Leadership
• Teaching
• Advice
• Representation
• Promotion

Funding from Cancer Council WA: $25,000 in 2022 (total $250,000 for 2018-2022)
Supported: In the name of the Jospeh & Betty Pitschel Pain Relief Fund